Brief: Perspective Therapeutics FY EPS USD -1.4
16/03/2026 20:07
Mar 16 (Reuters) - Perspective Therapeutics FY operating income USD -113.564 million. FY net income from cont ops USD -104.428 million FY net income USD -103.121 million FY grant revenue USD 884 thousand
Recent news on Perspective Therapeutics
See all newsBrief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise
U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson
Brief: Perspective Therapeutics FY EPS USD -1.4